Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Obstructive Lung Diseases

  Free Subscription


3 Allergy
2 Am J Respir Crit Care Med
2 Ann Allergy Asthma Immunol
7 Eur Respir J
1 J Allergy Clin Immunol
2 J Asthma
2 Pediatr Allergy Immunol
1 Pediatr Pulmonol
1 PLoS One
2 Respir Med
1 Respir Res
2 Rev Mal Respir

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


  1. ANDIAPPAN AK, Puan KJ, Sio YY, Ally F, et al
    Functional CTLA-4 variants associate to both allergic asthma and rhinitis potentially by modulating naive regulatory T cells.
    Allergy. 2022 May 24. doi: 10.1111/all.15386.

  2. CARRARO S, di Palmo E, Licari A, Barni S, et al
    Metabolomics to identify omalizumab responders among children with severe asthma: a prospective study.
    Allergy. 2022 May 23. doi: 10.1111/all.15385.

  3. KALLIERI M, Zervas E, Fouka E, Porpodis K, et al
    RELIght: A two-year REal-LIfe study of mepolizumab in patients with severe eosinophilic asTHma in Greece: evaluating the multiple components of response.
    Allergy. 2022 May 20. doi: 10.1111/all.15382.

    Am J Respir Crit Care Med

    Reply to: SARS-CoV-2 mRNA Vaccine Antibody Response in Asthma Patients with Biologic Therapy after Second and Booster Dose: A Real-world Analysis.
    Am J Respir Crit Care Med. 2022 May 25. doi: 10.1164/rccm.202205-0979.

  5. SCHUYLER AJ, Wenzel SE
    Historical Redlining Impacts Contemporary Environmental and Asthma-Related Outcomes in Black Adults.
    Am J Respir Crit Care Med. 2022 May 25. doi: 10.1164/rccm.202112-2707.
    PubMed         Abstract available

    Ann Allergy Asthma Immunol

  6. LIPWORTH DB, Stewart MK, Chan DR
    Pragmatic reappraisal of long acting muscarinic antagonists at steps 4/5 for persistent adult asthma: Invited Perspective article for Annals of Allergy, Asthma and Immunology.
    Ann Allergy Asthma Immunol. 2022 May 22. pii: S1081-1206(22)00449.

  7. HUDDLESTON CM, Slaven JE, Weist AD, Krupp NL, et al
    Increased Healthcare Utilization in Moderate to Severe Asthma Patients Due to Frequent Preferred Medication Changes.
    Ann Allergy Asthma Immunol. 2022 May 21. pii: S1081-1206(22)00448.

    Eur Respir J

  8. KAASGAARD M, Rasmussen DB, Andreasson KH, Hilberg O, et al
    Use of Singing for Lung Health as an alternative training modality within pulmonary rehabilitation for COPD: a randomised controlled trial.
    Eur Respir J. 2022;59.
    PubMed         Abstract available

  9. YUN JH, Lee S, Srinivasa P, Morrow J, et al
    An interferon-inducible signature of airway disease from blood gene expression profiling.
    Eur Respir J. 2022;59.
    PubMed         Abstract available

  10. VESTBO J, Waterer G, Leather D, Crim C, et al
    Mortality after admission with pneumonia is higher than after admission with an exacerbation of COPD.
    Eur Respir J. 2022;59.

  11. SORIANO JB, Hopkinson NS
    Sing out for COPD!
    Eur Respir J. 2022;59.

  12. HUMBERT M, Bourdin A, Taille C, Kamar D, et al
    Real-life omalizumab exposure and discontinuation in a large nationwide population-based study of pediatric and adult asthmatics.
    Eur Respir J. 2022 May 26. pii: 13993003.03130-2021.
    PubMed         Abstract available

  13. SUN Y, Zhang M, Ou Z, Meng Y, et al
    Indoor microbiome, microbial and plant metabolites, chemical compounds and asthma symptoms in junior high school students: a multicentre association study in Malaysia.
    Eur Respir J. 2022 May 26. pii: 13993003.00260-2022.
    PubMed         Abstract available

  14. WOEHLK C, Von Bulow A, Ghanizada M, Baastrup Sondergaard M, et al
    Allergen immunotherapy effectively reduces the risk of exacerbations and lower respiratory tract infections in both seasonal and perennial allergic asthma: a nationwide epidemiological study.
    Eur Respir J. 2022 May 26. pii: 13993003.00446-2022.
    PubMed         Abstract available

    J Allergy Clin Immunol

  15. CARDET JC, Chang KL, Rooks BJ, Carroll JK, et al
    Socioeconomic status associates with worse asthma morbidity among Black and Latinx adults.
    J Allergy Clin Immunol. 2022 May 18. pii: S0091-6749(22)00661.
    PubMed         Abstract available

    J Asthma

  16. OMARA H, Gamal M, Mohamed R
    Asthma Education and its Impact on Pediatric Asthma Severity: A Prospective Cohort Study.
    J Asthma. 2022 May 26:1-16. doi: 10.1080/02770903.2022.2082306.
    PubMed         Abstract available

  17. ALSUWAIGH R, Cao Y, Puan Y, Yii A, et al
    Nebulizer versus metered dose inhaler with space chamber (MDI spacer) for acute asthma and chronic obstructive pulmonary disease (COPD) exacerbation: attitudes of patients and healthcare providers in the COVID-19 era.
    J Asthma. 2022 May 24:1-12. doi: 10.1080/02770903.2022.2082307.
    PubMed         Abstract available

    Pediatr Allergy Immunol

  18. HERNANDEZ-PACHECO N, Kere M, Melen E
    Gene-environment interactions in childhood asthma revisited; expanding the interaction concept.
    Pediatr Allergy Immunol. 2022;33:e13780.
    PubMed         Abstract available

  19. GRANT TL, Wood RA
    The influence of urban exposures and residence on childhood asthma.
    Pediatr Allergy Immunol. 2022;33:e13784.
    PubMed         Abstract available

    Pediatr Pulmonol

  20. COGO A, Piazza M, Costella S, Appodia M, et al
    A positive effect of a short period stay in Alpine environment on lung function in asthmatic children.
    Pediatr Pulmonol. 2022 May 23. doi: 10.1002/ppul.25987.
    PubMed         Abstract available

    PLoS One

    Prevalence, incidence, morbidity and mortality rates of COPD in Saudi Arabia: Trends in burden of COPD from 1990 to 2019.
    PLoS One. 2022;17:e0268772.
    PubMed         Abstract available

    Respir Med

  22. SON JH, Park JS, Lee JU, Kim MK, et al
    A genome-wide association study on frequent exacerbation of asthma depending on smoking status.
    Respir Med. 2022 May 17:106877. doi: 10.1016/j.rmed.2022.106877.
    PubMed         Abstract available

  23. IKWU I, Nicolas LG, Mehari A, Gillum RF, et al
    Fractional exhaled nitric oxide and mortality in asthma and chronic obstructive pulmonary disease in a national cohort aged 40 years and older.
    Respir Med. 2022 May 16:106879. doi: 10.1016/j.rmed.2022.106879.
    PubMed         Abstract available

    Respir Res

  24. IHRIE MD, McQuade VL, Womble JT, Hegde A, et al
    Exogenous leptin enhances markers of airway fibrosis in a mouse model of chronic allergic airways disease.
    Respir Res. 2022;23:131.
    PubMed         Abstract available

    Rev Mal Respir

  25. JEBRAK G, Houdouin V, Terrioux P, Lambert N, et al
    [Therapeutic adherence among asthma patients: Variations according to age groups. How can it be improved? The potential contributions of new technologies].
    Rev Mal Respir. 2022 May 18. pii: S0761-8425(22)00101.
    PubMed         Abstract available

  26. MEDRINAL C, Bonnevie T
    [Physiotherapy during and after acute exacerbation of COPD].
    Rev Mal Respir. 2022;39:386-397.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.